Quell Therapeutics to Participate at Upcoming Healthcare Investor Conferences
November 06, 2024 07:30 ET
|
Quell TX
London, UK – November 6, 2024 – Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system,...